EP
MED icon

Edgestream Partners’s Medifast MED Stock Holding History

Edgestream Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,806
Closed -$2.05M – 599
2021
Q4 		$2.05M Buy
9,806
+6,330
+182% +$1.31M 0.13% 231
2021
Q3 		$670K Sell
3,476
-6,068
-64% -$1.49M 0.04% 362
2021
Q2 		$2.7M Buy
+9,544
New +$2.59M 0.16% 193

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Edgestream Partners's MED Position: Q1 2022 in Review

Edgestream Partners sold out of Medifast (MED) in Q1 2022, closing a stake of 9,806 shares — an estimated $2.05M sold.

Edgestream Partners first reported a position in MED in Q2 2021 and held it in 3 quarters. The position peaked at $2.7M in Q2 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Edgestream Partners reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
  • Edgestream Partners sold 9,806 Medifast shares in Q1 2022, an estimated $2.05M.
  • Edgestream Partners first reported a position in Medifast in Q2 2021 and held it in 3 quarters.
  • Edgestream Partners's Medifast position peaked at $2.7M in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Edgestream Partners's 13F filing for Q1 2022, filed 13 May 2022.